Rigel Pharmaceuticals Inc

Ownership Transactions Reported by 16 Insiders

Symbol
RIGL on Nasdaq
Location
611 Gateway Boulevard, Suite 900, South San Francisco, CA

Insiders trading volume in the past year

Rigel Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Raul R. Rodriguez CEO, President, Director $2.32M -$60.1K -2.52% Aug 30, 2024
Dean L. Schorno EVP & Chief Financial Officer $459K -$14.3K -3.03% Aug 30, 2024
David A. Santos EVP, Chief Commercial Officer $398K -$16.5K -3.98% Feb 28, 2024
Raymond J. Furey EVP, GC, CCO & Corp Sec $375K Feb 28, 2024
Gary A. Lyons Director $131K May 26, 2023
Wolfgang Dummer Evp & Cmo $127K Feb 2, 2023
Walter H. Moos Director $117K May 25, 2024
Jane Wasman Director $114K May 25, 2024
Gregg Lapointe Director $114K May 25, 2024
Brian L. Kotzin Director $114K May 25, 2024
Alison L. Hannah Director $92.6K May 25, 2024
Kamil Ali-Jackson Director $78.4K May 25, 2024
Bradford S. Goodwin Director $61.3K May 19, 2021
Keith Katkin Director $43.8K May 19, 2021
Dolly Vance EVP Corp. Affairs, G.C., Sect. Sep 14, 2022
Lisa Rojkjaer EVP, Chief Medical Officer Mar 27, 2024

Recent Insider Transactions by Companies or Individuals for Rigel Pharmaceuticals Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.